Aumgene Biosciences Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 17-07-2024
- Paid Up Capital ₹ 2.39 M
as on 17-07-2024
- Company Age 20 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 22.90 Cr
as on 17-07-2024
- Revenue 29.16%
(FY 2023)
- Profit 55.04%
(FY 2023)
- Ebitda 43.95%
(FY 2023)
- Net Worth 22.28%
(FY 2023)
- Total Assets 7.35%
(FY 2023)
About Aumgene Biosciences
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.39 M.
The company currently has active open charges totaling ₹22.90 Cr.
Anand Daga and Jaikumar Bajaj serve as directors at the Company.
- CIN/LLPIN
U24231GJ2004PTC044192
- Company No.
044192
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 May 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Surat, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Aumgene Biosciences Private Limited offer?
Aumgene Biosciences Private Limited offers a wide range of products and services, including Flavours & Aromatics, Food Enzymes, Papain, Fertilizers and Soil Additives, Bio Fertilizers, Fast Food & Beverages Machinery, Beverage Making Plant.
Who are the key members and board of directors at Aumgene Biosciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anand Daga  | Director | 26-May-2004 | Current |
| Jaikumar Bajaj | Director | 26-May-2004 | Current |
Financial Performance of Aumgene Biosciences.
Aumgene Biosciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 29.16% increase. The company also saw a substantial improvement in profitability, with a 55.04% increase in profit. The company's net worth Soared by an impressive increase of 22.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aumgene Biosciences?
In 2023, Aumgene Biosciences had a promoter holding of 23.44% and a public holding of 76.56%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Shree Radha Madhav Textiles Private LimitedActive 36 years 6 months
Jaikumar Bajaj is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 09 Nov 2023 | ₹9.95 Cr | Open |
Axis Bank Limited Creation Date: 20 Oct 2023 | ₹9.95 Cr | Open |
Biotechnology Industry Research Assistance Council Creation Date: 19 Mar 2014 | ₹5.00 M | Open |
How Many Employees Work at Aumgene Biosciences?
Aumgene Biosciences has a workforce of 56 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aumgene Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aumgene Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
